家禽疫苗市场、机会、成长动力、产业趋势分析与预测，2024-2032

Poultry Vaccines Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年08月02日 | 出版商:

Global Market Insights Inc. | 英文 195 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2023 年，全球家禽疫苗市场价值为 23 亿美元，预计 2024 年至 2032 年复合年增长率为 7.1%。增长和蛋白质消耗量的增加。特别是在新兴经济体，向富含蛋白质的饮食的转变刺激了对家禽养殖的投资，进一步增加了对有效疾病预防措施（尤其是动物疫苗）的需求。

粮食及农业组织 (FAO) 和经济合作暨发展组织 (OECD) 的预测强调，家禽产品的需求不断增长是主要的市场驱动力。他们预测，未来十年全球禽肉消费量将成长 15%，预计到 2032 年将达到 9,100 万吨。

整个产业分为产品、疾病类型、应用、剂型、最终用户和地区。

依产品细分，市场包括减毒活疫苗、灭活疫苗、重组疫苗等类型。减毒活疫苗在全球家禽疫苗市场占据主导地位，预计在预测期内将以 6.9% 的速度成长。减毒活疫苗引领市场，因其能引发强大且持久的免疫反应而受到青睐。它们提供快速的免疫力，对于保护幼鸟和迅速应对疫情至关重要。它们具有成本效益且适应性强，其生产和管理通常需要较少的剂量，这使其成为大规模家禽养殖的理想选择。

依疾病类型细分，家禽疫苗产业包括新城疫、传染性支气管炎、传染性法氏囊病、沙门氏菌、马立克氏症、滴蛋症候群、腺病毒、球虫病、禽流感、传染性喉气管炎、禽脑脊髓炎等。 2023 年，新城疫细分市场占最大市场份额，达到 20.8%。疫情导致巨大的经济损失，表现为死亡率升高、产蛋量减少和生长速度迟缓，往往导致受影响鸟类的扑杀增加。这种财务影响放大了家禽业对有效疫苗的需求。

北美引领全球家禽疫苗市场，预计将以7% 的速度成长，到2032 年估值将达到17 亿美元。。作为疫苗开发创新中心，北美在疫苗功效和给药方法方面的持续研究和进步将增强其市场成长潜力。

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 11 章：公司简介

Biovac
Boehringer Ingelheim International GmbH
Ceva Sante Animale
Dechra Pharmaceuticals PLC
Elanco Animal Health Incorporated
Hester Biosciences Limited
HIPRA
Merck and Co., Inc.
Phibro Animal Health Corporation
Vaxxinova International BV
Venky's Limited
Zoetis, Inc.

简介目录

Product Code: 10613

The Global Poultry Vaccines Market was valued at USD 2.3 billion in 2023 and is projected to grow at a CAGR of 7.1% from 2024 to 2032. This growth is driven by increasing global demand for poultry products, such as meat and eggs, fueled by population growth and rising protein consumption. Particularly in emerging economies, the shift towards protein-rich diets has spurred investments in poultry farming, further amplifying the need for effective disease prevention measures, notably animal vaccines.

Projections from the Food and Agriculture Organization (FAO) and the Organization for Economic Co-operation and Development (OECD) underscore the rising demand for poultry products as a key market driver. Their forecasts indicate a 15% growth in global poultry meat consumption over the next decade, estimating a reach of 91 million tons by 2032.

The overall industry is divided into product, disease type, application, dosage form, end-user, and region.

Segmented by product, the market includes attenuated live vaccines, inactivated vaccines, recombinant vaccines, and other types. Dominating the global poultry vaccines market, attenuated live vaccines are projected to grow at 6.9% during the forecast period. Leading the market, attenuated live vaccines are favored for their ability to elicit a robust and enduring immune response. They provide a swift immunity onset, vital for safeguarding young birds and addressing outbreaks promptly. Cost-effective and adaptable, their production and administration often require fewer doses, making them ideal for extensive poultry operations.

Segmented by disease type, the poultry vaccines industry encompasses Newcastle disease, infectious bronchitis, infectious bursal diseases, salmonella, Marek's disease, egg drop syndrome, adenovirus, coccidiosis, avian influenza, infectious laryngotracheitis, avian encephalomyelitis, among others. In 2023, the Newcastle disease segment held the largest market share at 20.8%. Outbreaks lead to substantial economic losses, manifesting as elevated mortality rates, diminished egg production, and stunted growth rates, often resulting in increased culling of affected birds. Such financial repercussions amplify the demand for effective vaccines in the poultry sector.

North America led the global poultry vaccines market and is projected to grow at 7%, aiming for a valuation of USD 1.7 billion by 2032. With its advanced farming practices and technologies, North America's poultry industry, especially in the U.S. and Canada, boasts sophisticated vaccination programs and stringent biosecurity measures, underpinning the regional market growth. As a center for vaccine development innovation, North America's continuous research and advancements in vaccine efficacy and delivery methods will bolster its market growth potential.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising demand for poultry products
  - 3.2.1.2 Increased outbreaks of poultry diseases
  - 3.2.1.3 Technological advancements in vaccine development
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High cost associated with vaccine development and production
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Attenuated live vaccines
5.3 Inactivated vaccines
5.4 Recombinant vaccines
5.5 Other vaccine types

Chapter 6 Market Estimates and Forecast, By Disease Type, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Newcastle disease
6.3 Infectious bronchitis
6.4 Infectious bursal diseases
6.5 Salmonella
6.6 Marek's disease
6.7 Egg drop syndrome
6.8 Adenovirus
6.9 Coccidiosis
6.10 Avian influenza
6.11 Infectious laryngotracheitis
6.12 Avian encephalomyelitis
6.13 Other disease types

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Breeder
7.3 Layer
7.4 Broiler

Chapter 8 Market Estimates and Forecast, By Dosage Form, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Liquid vaccine
8.3 Freeze dried vaccine

Chapter 9 Market Estimates and Forecast, By End-user, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 Veterinary hospitals and clinics
9.3 Poultry farms

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

10.1 Key trends
10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 France
- 10.3.4 Spain
- 10.3.5 Italy
- 10.3.6 Netherlands
- 10.3.7 Rest of Europe
10.4 Asia Pacific
- 10.4.1 China
- 10.4.2 Japan
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 South Korea
- 10.4.6 Rest of Asia Pacific
10.5 Latin America
- 10.5.1 Brazil
- 10.5.2 Mexico
- 10.5.3 Rest of Latin America
10.6 Middle East and Africa
- 10.6.1 South Africa
- 10.6.2 Saudi Arabia
- 10.6.3 UAE
- 10.6.4 Rest of Middle East and Africa